The Effects of Dark Chocolate on Blood Pressure in Individuals With Mildly Elevated Blood Pressure
NCT ID: NCT02130141
Last Updated: 2014-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2012-11-30
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Cocoa Intake on Blood Pressure in Elderly Individuals With Mild Hypertension
NCT00421499
Effects of Acute Ingestion of Dark Chocolate on Endothelial Function in Hypertensive Patients
NCT01314924
Effect of Different Dosages of Dark Chocolate on Arterial Blood Pressure in Cardiovascular High-risk Patients
NCT00661986
Effects of Dark Chocolate on Insulin Sensitivity in People With High Blood Pressure
NCT00099476
Controlled Clinical Trial to Determine the Effective Dose of Cocoa in Lowering Blood Pressure
NCT01276951
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dark chocolate, dietary counselling
Mildly hypertensive subject will replace their usual snacks with with 50 g dark chocolate daily for a period of 8 weeks.
Dark chocolate
Mildly hypertensive subject will replace their usual snacks with with 50 g dark chocolate daily for a period of 8 weeks.
Dietary counselling
Usual snacks are limited.
Dark chocolate
Mildly hypertensive subject will replace their usual snacks with with 50 g dark chocolate daily for a period of 8 weeks.
Dietary counselling
Usual snacks are limited.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dark chocolate
Mildly hypertensive subject will replace their usual snacks with with 50 g dark chocolate daily for a period of 8 weeks.
Dietary counselling
Usual snacks are limited.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* resting systolic pressure 140-159 mmHg or diastolic blood pressure 90-99 mmHg
* BMI 25.0- 29.9
Exclusion Criteria
* regular medication for hypertension, cardiovascular disease, diabetes or asthma
25 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fazer Group
INDUSTRY
University of Helsinki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mikael Fogelholm
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mikael Fogelholm, Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Helsinki
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Helsinki
Helsinki, Helsingin Yliopisto, Finland
Institute of Clinical Medicine
Helsinki, Uusimaa, Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Koli R, Kohler K, Tonteri E, Peltonen J, Tikkanen H, Fogelholm M. Dark chocolate and reduced snack consumption in mildly hypertensive adults: an intervention study. Nutr J. 2015 Aug 22;14:84. doi: 10.1186/s12937-015-0075-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HY-RAV-FAZ-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.